The great thing about calimmune news is that it is low risk / high reward. If Calimmune HIV phase 2 trial fails our stock won't go down very much as most people don't even know about the Benitec/Calimmune relationship. However if Calimmune get good phase two results the share price will likely see large gains.
Rerate vs. Quick Spike, page-10
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)